myze launches The Daily Lid Wipe, created with input from eye care professionals

News
Article

The lid wipe contains tea tree oil, hyaluronic acid, and other antibacterial and antimicrobial ingredients like euphrasia, chamomile, and rhamnose

Image credit: AdobeStock/Kabardinsphoto

Image credit: AdobeStock/Kabardinsphoto

Digital health platform myze has announced the launch of its first branded product, The Daily Lid Wipe, a modern lid wipe that contains tea tree oil, hyaluronic acid, and other antibacterial and antimicrobial ingredients like euphrasia, chamomile, and rhamnose. According to the news release, the wipe was formulated with the input of Laura M. Periman, MD and Cecelia Koetting, OD, FAAO, Dipl ABO.1

“Both my patients and I are really enjoying The Daily Lid Wipe from Myze,” Koetting said. “The formula is gentle, and the cloth's texture is enough to remove dirt and debris but soft without irritating the skin.”

The wipe is also “uniquely soft and gentle, yet highly effective in removing debris, leaving the eye area feeling cleansed and refreshed,1” the release stated.

“We have a very simple, yet audacious mission at myze: to make eye care part of everyone’s daily self care routine,” said Scott Tannenbaum, CEO and founder of myze. “After speaking to our customers for the last several years, it became quite apparent that there is a huge unmet need to educate on the importance of lid hygiene and provide customers access to a product that is unique and modern. The Daily Lid Wipe meets this need.”

Benjamin Chudner, chief medical officer of AEG Vision, reinstated this unmet need regarding patient education, including eyelid and lash hygiene and its impact on ocular surface disease. “We are partnering with myze and their new product launch, The Daily Lid Wipe, to ensure that our patients are getting the best possible products for their daily lid hygiene needs,” he said in the release.

Reference:
  1. Myze launches The Daily Wipe to make daily eye lid hygiene an integral part of daily self care for millions of patients. News release. myze. October 30, 2024. Accessed November 21, 2024.
Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.